相关实验视频

Updated: Jun 11, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

了解慢性髓性白血病的现有和未来治疗方法

Sourabh Tyagi¹, Anu Singh², Naveen Sharma³

¹Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi, India.

The Indian journal of medical research

|October 9, 2024

概括

慢性髓性白血病 (CML) 治疗已经通过向治疗,如铁氨酸激酶抑制剂 (TKIs) 取得了进展. 然而,耐药性需要探索包括CRISPR/Cas9在内的新方法,以消除潜在的CML.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

慢性髓性白血病 (CML) 是由BCR-ABL1融合瘤基因驱动的,导致构成性氨酸激酶活性.
针对CML的传统治疗方法已在很大程度上被向疗法所取代,特别是氨酸激酶抑制剂 (TKI).
对BCR-ABL1依赖和独立的TKIs的阻力在CML管理中是一个重大挑战.

研究的目的:

审查CML目前的诊断和治疗策略.
探索CML中新兴的治疗剂和抵抗机制.
评估CRISPR/Cas9作为CML治疗策略的潜力.

主要方法:

关于CML诊断,治疗和抵抗机制的文献综述.
对新型CML治疗药物的正在进行的临床试验的分析.
探索CRISPR/Cas9作为一种潜在的基因编辑疗法.

主要成果:

氨酸激酶抑制剂 (TKIs) 已经彻底改变了CML治疗,但面临着耐药性问题.
许多下一代药物正在临床研究中,以克服耐药性.
克里斯普尔/Cas9技术显示出作为一种潜在的CML治疗方法的希望.

结论:

尽管有进展,但CML治疗需要持续创新,因为耐药性.
新药开发和基因编辑技术,如CRISPR/Cas9,为未来的治疗提供了新的途径.
在CML中,CRISPR/Cas9具有显著的潜力,可以实现治愈结果.

关键词:

这就是CRISPR/CasPR.慢性骨髓性白血病慢性骨髓性白血病临床试验临床试验临床试验临床试验临床试验药物耐药性耐药性药物耐药性没有治疗的耐药性 (TFR)氨酸激酶抑制剂 (TKI) 的使用

更多相关视频

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Modeling Chemotherapy Resistant Leukemia In Vitro

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...